Intrexon T1D Partners
2016
FOUNDED
PRIVATE
STATUS
Joint Venture
LATEST DEAL TYPE
1
FINANCING ROUNDS
Description
Developer of a therapy for the treatment of Type 1 diabetes. The company is focused on development of an antigen-specific immunotherapy both for early-stage patients before they become insulin dependent, and in certain advanced-stage patients for the potential prevention of the requirement for external administration of insulin.
Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
- 20374 Seneca Meadows Parkway
- Germantown, MD 20876
- United States
Intrexon T1D Partners Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Intrexon T1D Partners‘s full profile, request access.
Request full access to PitchBookIntrexon T1D Partners Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore Intrexon T1D Partners‘s full profile, request access.
Request full access to PitchBook